Categories: Wire Stories

Asia-Pacific Catheters Industry Assessment 2019-2025 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Asia-Pacific Catheters Market 2019-2025” report has been added to ResearchAndMarkets.com’s offering.

Asia-Pacific catheters market is expected to grow at a CAGR of around 9.4% during the forecast period.

The major factors contributing to the growth of the market in the region include the rising geriatric population and prevalence of chronic diseases in them continue to spur the demand for catheterization in healthcare centers, hospitals and surgical units. CVDs are the leading cause of mortality in India. As per the American Heart Association (AHA), in India, ischemic heart disease and stroke are the predominant causes and are responsible for more than 80% of CVD deaths.

In China, a rise in the prevalence of CVD risk and population aging increased the risk of acute myocardial infarctions (AMIs) and strokes among the population. The prevalence is also rising among adults in the country. As per the estimation by the World Heart Federation, one in 5 adults in China has a CVD.

This significant prevalence of CVD accelerates the demand for CVD catheters in the region. A cardiac catheter is a thin tubular structure inserted into a chamber of the patient’s heart for treating CVD conditions. Different types of cardiac catheters are used for the treatment of cardiac conditions, including angiographic balloon catheters, semi-floating catheters, and infusion catheters.

The major companies operating in the region include Abbott Laboratories, Inc., Boston Scientific Corp., and Medtronic plc. To survive in the market, these players are adopting crucial strategies, such as mergers and acquisitions, product launches, and partnerships and collaborations. This enables the company to increase its competitiveness and attract significant share in the market.

For instance, in July 2016, Boston Scientific Corp. introduced an integrated facility in India for developing minimally invasive technologies. The company has opened R&D and training & development center of 100,000 (Square Feet) to develop and sell minimally invasive devices, including pacemakers, catheters and stents for India and the major Asian markets as well as train physicians to use these devices.

This report covers:

  • A comprehensive research methodology of the Asia-Pacific catheters market.
  • A detailed and extensive market overview with key analyst insights.
  • Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the Asia-Pacific catheters market.
  • Insights about market determinants which are stimulating the Asia-Pacific catheters market.
  • Detailed and extensive market segments with regional distribution of forecast revenues.
  • Extensive profiles and recent developments of market players.

Key Topics Covered

1. Report Summary

1.1. Research Methods and Tools

1.2. Market Breakdown

1.2.1. By Segments

1.2.2. By Country

2. Market Overview and Insights

2.1. Scope of the Report

2.2. Analyst Insight & Current Market Trends

2.2.1. Key Findings

2.2.2. Recommendations

2.2.3. Conclusion

2.3. Rules & Regulations

3. Competitive Landscape

3.1. Company Share Analysis

3.2. Key Strategy Analysis

3.3. Key Company Analysis

3.3.1. Overview

3.3.2. Financial Analysis

3.3.3. SWOT Analysis

3.3.4. Recent Developments

4. Market Determinants

4.1. Motivators

4.2. Restraints

4.3. Opportunities

5. Market Segmentation

5.1. Asia-Pacific Catheters Market by Product Type

5.1.1. Cardiovascular Catheters

5.1.2. Urological Catheters

5.1.3. Intravenous Catheters

5.1.4. Specialty Catheters

5.1.5. Neurovascular Catheters

6. Regional Analysis

6.1. China

6.2. India

6.3. Japan

6.4. Rest of Asia-Pacific

7. Company Profiles

7.1. Abbott Laboratories, Inc.

7.2. Becton Dickinson and Co.

7.3. Boston Scientific Corp.

7.4. Edwards Lifesciences Corp.

7.5. Integra Lifesciences Corp.

7.6. Johnson & Johnson Services, Inc.

7.7. Medtronic plc

7.8. Olympus Corp.

7.9. Stryker Corp.

7.10. Terumo Medical Corp.

For more information about this report visit https://www.researchandmarkets.com/r/jja5eb

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Alex

Alex is a writer and digital content enthusiast who enjoys covering technology, current trends, useful tips, and topics that matter to everyday readers. With a focus on clear, informative, and easy-to-understand content, Alex aims to provide readers with practical insights and interesting perspectives across a wide range of subjects.

Recent Posts

Spain vs Czechia: Why Luis de la Fuente Is Leaving Out Cubarsí, Espí and Resting a Barcelona Defender

Key takeaways:Luis de la Fuente surprised fans by leaving out Pau Cubarsí and Espí for…

11 minutes ago

Switzerland vs Slovenia: Nations League Preview, Stats and Betting Insights

Key takeaways:Switzerland are favoured over Slovenia in their UEFA Nations League match in Lucerne, according…

41 minutes ago

Gurnoor Brar’s Role in India’s ODI Squad: Why the Cost Is Worth It

Key takeaways:Gurnoor Brar has been added to India's ODI squad for the third West Indies…

4 hours ago

World Championship of Legends 2026: Teams, First Match, and New Franchise Owner

Key takeaways:WCL 2026 has started with the INDCH vs AUSCH opening match.Vauve Global now owns…

4 hours ago

Yuvraj Singh’s Record Tied and Broken by Abhishek Sharma: What It Means for Indian Cricket

Key takeaways:Abhishek Sharma has matched a major Yuvraj Singh record against Pakistan, according to The…

5 hours ago

Drishyam 3 Box Office Collection: Biggest Opener Ever for Ajay Devgn?

Key takeaways:Drishyam 3 opened as the biggest opener ever for Ajay Devgn, according to news…

5 hours ago